{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:09:56Z","timestamp":1793984996083,"version":"4.8.0"},"reference-count":107,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2015,12,8]],"date-time":"2015-12-08T00:00:00Z","timestamp":1449532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Enterovirus 71 (EV71) is a group of viruses that belongs to the Picornaviridae family, which also includes viruses such as polioviruses. EV71, together with coxsackieviruses, is widely known for its association with Hand Foot Mouth Disease (HFMD), which generally affects children age five and below. Besides HFMD, EV71 can also trigger more severe and life-threatening neurological conditions such as encephalitis. Considering the lack of a vaccine and antiviral drug against EV71, together with the increasing spread of these viruses, the development of such drugs and vaccines becomes the top priority in protecting our younger generations. This article, hence, reviews some of the recent progress in the formulations of anti-therapeutics and vaccine generation for EV71, covering (i) inactivated vaccines; (ii) baculovirus-expressed vaccines against EV71; (iii) human intravenous immunoglobulin (IVIg) treatment; and (iv) the use of monoclonal antibody therapy as a prevention and treatment for EV71 infections.<\/jats:p>","DOI":"10.3390\/v7122949","type":"journal-article","created":{"date-parts":[[2015,12,9]],"date-time":"2015-12-09T15:21:41Z","timestamp":1449674501000},"page":"6441-6457","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Recent Progress towards Novel EV71 Anti-Therapeutics and Vaccines"],"prefix":"10.3390","volume":"7","author":[{"given":"Qingyong","family":"Ng","sequence":"first","affiliation":[{"name":"Animal Health Biotechnology, Temasek Life Sciences Laboratory, 1 Research Link, National University of Singapore, 117604 Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"He","sequence":"additional","affiliation":[{"name":"Animal Health Biotechnology, Temasek Life Sciences Laboratory, 1 Research Link, National University of Singapore, 117604 Singapore"},{"name":"College of Animal Sciences, Zhejiang University, Yuhangtang Road 866, Hangzhou 310013, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Kwang","sequence":"additional","affiliation":[{"name":"Animal Health Biotechnology, Temasek Life Sciences Laboratory, 1 Research Link, National University of Singapore, 117604 Singapore"},{"name":"Department of Microbiology Faculty of Medicine, National University of Singapore, 117604 Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2015,12,8]]},"reference":[{"key":"ref_1","first-page":"43","article-title":"The hand, foot and mouth disease virus capsid: Sequence analysis and prediction of antigenic sites from homology modelling","volume":"1","author":"Ranganathan","year":"2002","journal-title":"Appl. Bioinform."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Plevka, P., Perera, R., Cardosa, J., Kuhn, R.J., Rossmann, M.G., and Rossmann, M.G. (2012). Crystal structure of human enterovirus 71. Science, 336.","DOI":"10.2210\/pdb4aed\/pdb"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nsmb.2255","article-title":"A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71","volume":"19","author":"Wang","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Huang, S.-W., Cheng, H.-L., Hsieh, H.-Y., Chang, C.-L., Tsai, H.-P., Kuo, P.-H., Wang, S.-M., Liu, C.-C., Su, I.-J., and Wang, J.-R. (2014). Mutations in the non-structural protein region contribute to intra-genotypic evolution of Enterovirus 71. J. Biomed. Sci., 21.","DOI":"10.1186\/1423-0127-21-33"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1128\/JVI.01019-09","article-title":"Evolutionary genetics of human enterovirus 71: Origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene","volume":"84","author":"Tee","year":"2010","journal-title":"J. Virol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJM199909233411301","article-title":"An epidemic of Enterovirus 71 infection in taiwan. Taiwan enterovirus epidemic working group","volume":"341","author":"Ho","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/infdis\/129.3.304","article-title":"An apparently new enterovirus isolated from patients with disease of the central nervous system","volume":"129","author":"Schmidt","year":"1974","journal-title":"J. Infect. Dis."},{"key":"ref_8","first-page":"297","article-title":"Deaths in children during an outbreak of hand, foot and mouth disease in peninsular malaysia\u2014Clinical and pathological characteristics","volume":"60","author":"Shekhar","year":"2005","journal-title":"Med. J. Malays."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1386-6532(00)00068-8","article-title":"An outbreak of Enterovirus 71 infection in taiwan, 1998: Epidemiologic and clinical manifestations","volume":"17","author":"Liu","year":"2000","journal-title":"J. Clin. Virol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1128\/JCM.00630-09","article-title":"Reemergence of Enterovirus 71 in 2008 in Taiwan: Dynamics of genetic and antigenic evolution from 1998 to 2008","volume":"47","author":"Huang","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.47102\/annals-acadmedsg.V38N2p106","article-title":"Epidemiology and control of hand, foot and mouth disease in Singapore, 2001\u20132007","volume":"38","author":"Ang","year":"2009","journal-title":"Ann. Acad. Med. Singap."},{"key":"ref_12","unstructured":"Emerging Disease Surveillance and Response. Available online: http:\/\/www.wpro.who.int\/emerging_diseases\/en\/."},{"key":"ref_13","unstructured":"Fenner, F., Henderson, D.A., Arita, I., Jezek, Z., and Ladnyi, I.D. (1988). Smallpox and Its Eradication, WHO."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/08998280.2005.11928028","article-title":"Edward jenner and the history of smallpox and vaccination","volume":"18","author":"Riedel","year":"2005","journal-title":"Proc. Baylor Univ. Med. Cent."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.4161\/hv.24949","article-title":"Progress on the research and development of inactivated EV71 whole-virus vaccines","volume":"9","author":"Liang","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Liang, Z., and Wang, J. (2014). EV71 vaccine, an invaluable gift for children. Clin. Trans. Immunol., 3.","DOI":"10.1038\/cti.2014.24"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(13)61049-1","article-title":"Efficacy, safety, and immunology of an inactivated alum-adjuvant Enterovirus 71 vaccine in children in China: A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"381","author":"Zhu","year":"2013","journal-title":"Lancet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1303224","article-title":"An inactivated Enterovirus 71 vaccine in healthy children","volume":"370","author":"Li","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, safety, and immunogenicity of an Enterovirus 71 vaccine in China","volume":"370","author":"Zhu","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1586\/erv.13.18","article-title":"Immune responses to baculovirus-displayed Enterovirus 71 VP1 antigen","volume":"12","author":"Kiener","year":"2013","journal-title":"Expert Rev. Vaccines"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e21757","DOI":"10.1371\/journal.pone.0021757","article-title":"Display of VP1 on the surface of baculovirus and its immunogenicity against heterologous human Enterovirus 71 strains in mice","volume":"6","author":"Meng","year":"2011","journal-title":"PLoS ONE"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e29751","DOI":"10.1371\/journal.pone.0029751","article-title":"Characterization of an isotype-dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of Enterovirus 71 infection","volume":"7","author":"Lim","year":"2012","journal-title":"PLoS ONE"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e2895","DOI":"10.1371\/journal.pntd.0002895","article-title":"A novel universal neutralizing monoclonal antibody against Enterovirus 71 that targets the highly conserved \u201cknob\u201d region of VP3 protein","volume":"8","author":"Kiener","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Chang, G.-H., Luo, Y.-J., Wu, X.-Y., Si, B.-Y., Lin, L., and Zhu, Q.-Y. (2010). Monoclonal antibody induced with inactived EV71-Hn2 virus protects mice against lethal EV71-Hn2 virus infection. Virol. J., 7.","DOI":"10.1186\/1743-422X-7-106"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e79783","DOI":"10.1371\/journal.pone.0079783","article-title":"Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers","volume":"8","author":"Chou","year":"2013","journal-title":"PLoS ONE"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e79599","DOI":"10.1371\/journal.pone.0079599","article-title":"The cross-neutralizing activity of Enterovirus 71 subgenotype C4 vaccines in healthy chinese infants and children","volume":"8","author":"Mao","year":"2013","journal-title":"PLoS ONE"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"11955","DOI":"10.1128\/JVI.01809-14","article-title":"Effect of formaldehyde inactivation on poliovirus","volume":"88","author":"Wilton","year":"2014","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/088282403763635465","article-title":"Antibody-dependent enhancement of virus infection and disease","volume":"16","author":"Tirado","year":"2003","journal-title":"Viral Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1128\/CVI.00108-10","article-title":"Enterovirus 71 infection of monocytes with antibody-dependent enhancement","volume":"17","author":"Wang","year":"2010","journal-title":"Clin. Vaccine Immunol. CVI"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Han, J.-F., Cao, R.-Y., Deng, Y.-Q., Tian, X., Jiang, T., Qin, E.D., and Qin, C.-F. (2011). Antibody dependent enhancement infection of Enterovirus 71 in vitro and in vivo. Virol. J., 8.","DOI":"10.1186\/1743-422X-8-106"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e64024","DOI":"10.1371\/journal.pone.0064024","article-title":"Human IgG subclasses against enterovirus type 71: Neutralization versus antibody dependent enhancement of infection","volume":"8","author":"Cao","year":"2013","journal-title":"PLoS ONE"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1016\/j.vaccine.2011.01.094","article-title":"Formaldehyde-inactivated human Enterovirus 71 vaccine is compatible for co-immunization with a commercial pentavalent vaccine","volume":"29","author":"Chen","year":"2011","journal-title":"Vaccine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/CMR.14.2.430-445.2001","article-title":"Vaccination strategies for mucosal immune responses","volume":"14","author":"Ogra","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0076-6879(09)63014-7","article-title":"Baculovirus-insect cell expression systems","volume":"463","author":"Jarvis","year":"2009","journal-title":"Methods Enzymol."},{"key":"ref_35","first-page":"399","article-title":"Strong and regulated expression of Escherichia coli \u03b2-galactosidase in insect cells with a baculovirus vector","volume":"4","author":"Pennock","year":"1984","journal-title":"Mol. Cell. Biol."},{"key":"ref_36","first-page":"2156","article-title":"Production of human \u03b2 interferon in insect cells infected with a baculovirus expression vector","volume":"3","author":"Smith","year":"1983","journal-title":"Mol. Cell. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev.mi.42.100188.001141","article-title":"Baculoviruses as gene expression vectors","volume":"42","author":"Miller","year":"1988","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nbt0188-47","article-title":"Trends in the development of baculovirus expression vectors","volume":"6","author":"Luckow","year":"1988","journal-title":"Nat. Biotechnol."},{"key":"ref_39","unstructured":"O\u2019Reilly, D.R., Miller, L.K., and Luckow, V.A. (1994). Baculovirus Expression Vectors: A Laboratory Manual, Oxford University Press on Demand."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1128\/JVI.01412-10","article-title":"The receptor-binding domain of influenza virus hemagglutinin produced in Escherichia coli folds into its native, immunogenic structure","volume":"85","author":"DuBois","year":"2011","journal-title":"J. Virol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1017\/S1479236207001817","article-title":"Expression of H5N1 avian influenza virus haemagglutinin in a baculovirus expression system","volume":"4","author":"Jifeng","year":"2007","journal-title":"Chin. J. Agric. Biotechnol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/viro.1996.0193","article-title":"Functional and immunological properties of the baculovirus-expressed hemagglutinin of African swine fever virus","volume":"218","author":"Rodriguez","year":"1996","journal-title":"Virology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e63856","DOI":"10.1371\/journal.pone.0063856","article-title":"Intranasal immunization of baculovirus displayed hemagglutinin confers complete protection against mouse adapted highly pathogenic H7N7 reassortant influenza virus","volume":"8","author":"Kiener","year":"2013","journal-title":"PLoS ONE"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/nbt1036","article-title":"Baculovirus expression system for heterologous multiprotein complexes","volume":"22","author":"Berger","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nbt1095","article-title":"Baculovirus as versatile vectors for protein expression in insect and mammalian cells","volume":"23","author":"Kost","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e3933","DOI":"10.1371\/journal.pone.0003933","article-title":"Safety and immunogenicity of H5N1 influenza vaccine based on baculovirus surface display system of Bombyx mori","volume":"3","author":"Jin","year":"2008","journal-title":"PLoS ONE"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.vaccine.2010.11.045","article-title":"Baculovirus surface display of e envelope glycoprotein of Japanese encephalitis virus and its immunogenicity of the displayed proteins in mouse and swine models","volume":"29","author":"Xu","year":"2011","journal-title":"Vaccine"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.antiviral.2012.05.017","article-title":"Induction of protective immune responses against EV71 in mice by baculovirus encoding a novel expression cassette for capsid protein VP1","volume":"95","author":"Premanand","year":"2012","journal-title":"Antivir. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1586\/erv.10.115","article-title":"Virus-like particles in vaccine development","volume":"9","author":"Mellado","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Mariani, L., and Venuti, A. (2010). Hpv vaccine: An overview of immune response, clinical protection, and new approaches for the future. J. Transl. Med., 8.","DOI":"10.1186\/1479-5876-8-105"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.1016\/j.vaccine.2010.08.052","article-title":"Enterovirus 71 virus-like particle vaccine: Improved production conditions for enhanced yield","volume":"28","author":"Chung","year":"2010","journal-title":"Vaccine"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e57601","DOI":"10.1371\/journal.pone.0057601","article-title":"Neutralizing antibodies induced by recombinant virus-like particles of Enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps","volume":"8","author":"Ku","year":"2013","journal-title":"PLoS ONE"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/bit.25625","article-title":"Enhanced Enterovirus 71 virus-like particle yield from a new baculovirus design","volume":"112","author":"Lin","year":"2015","journal-title":"Biotechnol. Bioeng."},{"key":"ref_54","first-page":"201","article-title":"The assemblage, purification and characterization of EV71 VLPs expressed in baculovirus","volume":"28","author":"Cao","year":"2012","journal-title":"Chin. J. Virol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1128\/jvi.63.3.1393-1399.1989","article-title":"Identification and sequence analysis of a gene encoding GP67, an abundant envelope glycoprotein of the baculovirus autographa californica nuclear polyhedrosis virus","volume":"63","author":"Whitford","year":"1989","journal-title":"J. Virol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1016\/j.vaccine.2011.04.010","article-title":"Identification and characterization of a cross-neutralization epitope of Enterovirus 71","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"11363","DOI":"10.1128\/JVI.01926-13","article-title":"A strain-specific epitope of Enterovirus 71 identified by cryo-electron microscopy of the complex with fab from neutralizing antibody","volume":"87","author":"Lee","year":"2013","journal-title":"J. Virol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"498","DOI":"10.7150\/thno.7457","article-title":"Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop","volume":"4","author":"Xu","year":"2014","journal-title":"Theranostics"},{"key":"ref_59","unstructured":"He, D.L., Xia, N.S., Xu, F.H., Cheng, T., Weng, Z.X., Ge, S.X., Chen, Y.X., and Chen, Z.M. (2012). Enterovirus 71 Neutralized Epitope Polypeptide and Application Thereof. (CN102690327 A)."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.1007\/s00253-015-6652-8","article-title":"Generation and characterization of a protective mouse monoclonal antibody against human enterovirus 71","volume":"99","author":"Deng","year":"2015","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1128\/JVI.03098-14","article-title":"The enterovirus 71 procapsid binds neutralizing antibodies and rescues virus infection in vitro","volume":"89","author":"Shingler","year":"2015","journal-title":"J. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s12250-015-3573-8","article-title":"Monoclonal neutralizing antibodies against ev71 screened from mice immunized with yeast-produced virus-like particles","volume":"30","author":"Lin","year":"2015","journal-title":"Virol. Sin."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1089\/mab.2013.0033","article-title":"Monoclonal antibodies for diagnosis of Enterovirus 71","volume":"32","author":"Xu","year":"2013","journal-title":"Monoclon. Antib. Immunodiagn. Immunother."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.virol.2008.08.002","article-title":"Protective immunity against influenza h5n1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant","volume":"380","author":"Prabakaran","year":"2008","journal-title":"Virology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cellimm.2009.12.005","article-title":"Baculovirus activates murine dendritic cells and induces non-specific NK cell and T cell immune responses","volume":"262","author":"Suzuki","year":"2010","journal-title":"Cell. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1128\/CVI.05114-11","article-title":"Subcutaneous immunization with baculovirus surface-displayed hemagglutinin of pandemic H1N1 influenza A virus induces protective immunity in mice","volume":"18","author":"Prabakaran","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"9944","DOI":"10.1128\/JVI.73.12.9944-9951.1999","article-title":"Baculovirus stimulates antiviral effects in mammalian cells","volume":"73","author":"Gronowski","year":"1999","journal-title":"J. Virol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.virol.2009.06.017","article-title":"Localization of VP28 on the baculovirus envelope and its immunogenicity against white spot syndrome virus in penaeus monodon","volume":"391","author":"Madhan","year":"2009","journal-title":"Virology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1099\/0022-1317-78-6-1507","article-title":"Knebel-Morsdorf, D. Baculovirus transactivator ie1 is functional in mammalian cells","volume":"78","author":"Murges","year":"1997","journal-title":"J. Gen. Virol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Leung, C.S.K. (2015). Endogenous antigen presentation of MHC class II epitopes through non-autophagic pathways. Front. Immunol., 6.","DOI":"10.3389\/fimmu.2015.00464"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.gt.3301433","article-title":"Mhc class II presentation of endogenously expressed antigens by transfected dendritic cells","volume":"8","author":"Diebold","year":"2001","journal-title":"Gene Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nri3128","article-title":"Molecular programming of B cell memory","volume":"12","author":"Okitsu","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Murphy, K.P., Travers, P., Walport, M., and Janeway, C. (2008). Janeway\u2019s Immunobiology, Garland Science.","DOI":"10.1007\/978-3-8274-2219-4"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/sj.bjc.6690780","article-title":"Lack of MHC class I surface expression on neoplastic cells and poor activation of the secretory pathway of cytotoxic cells in oral squamous cell carcinomas","volume":"81","author":"Cruz","year":"1999","journal-title":"Br. J. Cancer"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3390\/vaccines2030624","article-title":"Developments in viral vector-based vaccines","volume":"2","author":"Ura","year":"2014","journal-title":"Vaccines"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2005.02834.x","article-title":"Clinical uses of intravenous immunoglobulin","volume":"142","author":"Jolles","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.61.6.736","article-title":"Practice parameter: Immunotherapy for guillain-barre syndrome: Report of the quality standards subcommittee of the american academy of neurology","volume":"61","author":"Hughes","year":"2003","journal-title":"Neurology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jcv.2006.05.009","article-title":"Modulation of cytokine production by intravenous immunoglobulin in patients with Enterovirus 71-associated brainstem encephalitis","volume":"37","author":"Wang","year":"2006","journal-title":"J. Clin. Virol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1875-9572(08)60024-8","article-title":"Enterovirus 71, one virus and many stories","volume":"49","author":"Wang","year":"2008","journal-title":"Pediatr. Neonatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1086\/649012","article-title":"Presence of high-titer neutralizing antibodies against Enterovirus 71 in intravenous immunoglobulin manufactured from Chinese donors","volume":"50","author":"Cao","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.tips.2004.04.002","article-title":"Intravenous immunoglobulin for infectious diseases: Back to the pre-antibiotic and passive prophylaxis era?","volume":"25","author":"Bayry","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1182\/blood.V98.4.1095","article-title":"Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: Studies in experimental immune thrombocytopenia","volume":"98","author":"Teeling","year":"2001","journal-title":"Blood"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1084\/jem.20061788","article-title":"The antiinflammatory activity of IgG: The intravenous IgG paradox","volume":"204","author":"Nimmerjahn","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2249.2004.02412.x","article-title":"Increased risk of adverse events when changing intravenous immunoglobulin preparations","volume":"136","author":"Ameratunga","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2340\/00015555-0900","article-title":"Not all intravenous immunoglobulin preparations are equally well tolerated","volume":"90","author":"Feldmeyer","year":"2010","journal-title":"Acta Derm. Venereol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJM199412153312409","article-title":"Transmission of viral infections through intravenous immune globulin","volume":"331","author":"Schiff","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/clpt.2008.170","article-title":"Monoclonal antibody pharmacokinetics and pharmacodynamics","volume":"84","author":"Wang","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_88","unstructured":"Yokoyama, W.M., Christensen, M., Dos Santos, G., Miller, D., Ho, J., Wu, T., Dziegelewski, M., and Neethling, F.A. (2006). Production of monoclonal antibodies. Curr. Prot. Immunol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0300-483X(95)03123-W","article-title":"Side-effects of a monoclonal antibody, muromonab CD3\/orthoclone OKT3: Bibliographic review","volume":"105","author":"Sgro","year":"1995","journal-title":"Toxicology"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.4049\/jimmunol.135.2.1299","article-title":"The interaction of murine IgG subclass proteins with human monocyte fc receptors","volume":"135","author":"Lubeck","year":"1985","journal-title":"J. Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.4049\/jimmunol.135.3.1975","article-title":"Structural requirements of immunoglobulin G for binding to the Fc \u03b3 receptors of the human tumor cell lines U937, HL-60, ML-1, AND K562","volume":"135","author":"McCool","year":"1985","journal-title":"J. Immunol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/cmi.2013.25","article-title":"Generation of human neutralizing monoclonal antibodies against the 2009 pandemic H1N1 virus from peripheral blood memory b lymphocytes","volume":"10","author":"Wang","year":"2013","journal-title":"Cell. Mol. Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm1080","article-title":"An efficient method to make human monoclonal antibodies from memory B cells: Potent neutralization of SARS coronavirus","volume":"10","author":"Traggiai","year":"2004","journal-title":"Nat. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4161\/mabs.2.3.11641","article-title":"The immunogenicity of humanized and fully human antibodies: Residual immunogenicity resides in the CDR regions","volume":"2","author":"Harding","year":"2010","journal-title":"mAbs"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0958-1669(95)80093-X","article-title":"Production of fully human antibodies by transgenic mice","volume":"6","author":"Jakobovits","year":"1995","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nbt1135","article-title":"Human antibodies from transgenic animals","volume":"23","author":"Lonberg","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/368856a0","article-title":"Antigen-specific human antibodies from mice comprising four distinct genetic modifications","volume":"368","author":"Lonberg","year":"1994","journal-title":"Nature"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/ng0594-13","article-title":"Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs","volume":"7","author":"Green","year":"1994","journal-title":"Nat. Genet."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nri1837","article-title":"Potent antibody therapeutics by design","volume":"6","author":"Carter","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.1073\/pnas.86.17.6709","article-title":"A repertoire of monoclonal antibodies with human heavy chains from transgenic mice","volume":"86","author":"Caskey","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/314268a0","article-title":"A hapten-specific chimaeric IgE antibody with human physiological effector function","volume":"314","author":"Neuberger","year":"1985","journal-title":"Nature"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.1073\/pnas.81.21.6851","article-title":"Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains","volume":"81","author":"Morrison","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_103","first-page":"457","article-title":"Humanisation of monoclonal antibodies for therapy","volume":"2","author":"Gorman","year":"1990","journal-title":"Semin. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymeth.2005.01.001","article-title":"Immunogenicity of engineered antibodies","volume":"36","author":"Hwang","year":"2005","journal-title":"Methods"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1128\/JVI.03014-14","article-title":"A novel humanized antibody neutralizes H5N1 influenza virus via two different mechanisms","volume":"89","author":"Tan","year":"2015","journal-title":"J. Virol."},{"key":"ref_106","unstructured":"Janeway, C.A., Travers, P., Walport, M., and Shlomchik, M.J. (2001). Garland Science."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40425-014-0029-x","article-title":"The role of Fc \u03b3 receptors in the activity of immunomodulatory antibodies for cancer","volume":"2","author":"Stewart","year":"2014","journal-title":"J. ImmunoTher. Cancer"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/7\/12\/2949\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:53:39Z","timestamp":1760216019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/7\/12\/2949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,8]]},"references-count":107,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12]]}},"alternative-id":["v7122949"],"URL":"https:\/\/doi.org\/10.3390\/v7122949","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,8]]}}}